Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03644069
Recruitment Status : Unknown
Verified March 2019 by ImmusanT, Inc..
Recruitment status was:  Active, not recruiting
First Posted : August 23, 2018
Last Update Posted : March 19, 2019
Sponsor:
Information provided by (Responsible Party):
ImmusanT, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : September 2019